ANEBULO PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 2.02 million shares as of 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-02-12
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.02M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.92M shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.82M shares.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.37M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2025-12-31 | 2.02M shares 10-Q · filed 2026-02-12 |
| 2025-09-30 | 1.92M shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 1.82M shares 10-K · filed 2025-09-29 |
| 2025-03-31 | 1.37M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 1.27M shares 10-Q · filed 2025-02-14 |
| 2024-09-30 | 903.99K shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 813.42K shares 10-K · filed 2024-09-25 |
| 2024-03-31 | 705.69K shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 1.01M shares 10-Q · filed 2024-02-13 |
| 2023-09-30 | 882.22K shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 829.11K shares 10-K · filed 2023-09-22 |
| 2023-03-31 | 661.87K shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 373.48K shares 10-Q · filed 2023-02-10 |
| 2022-09-30 | 315.39K shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 304.91K shares 10-K · filed 2022-09-09 |
| 2022-03-31 | 225.74K shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 81.29K shares 10-Q · filed 2022-02-11 |
| 2021-09-30 | 62.66K shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 59.66K shares 10-K · filed 2021-09-22 |
| 2021-03-31 | 383.42K shares 10-Q · filed 2021-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |